- Home
- BCBP vs PLX Comparison
BCBP vs PLX Comparison
Compare BCBP & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- PLX
- Stock Information
- Founded
- BCBP 2000
- PLX 1993
- Country
- BCBP United States
- PLX United States
- Employees
- BCBP N/A
- PLX N/A
- Industry
- BCBP Savings Institutions
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCBP Finance
- PLX Health Care
- Exchange
- BCBP Nasdaq
- PLX Nasdaq
- Market Cap
- BCBP 143.5M
- PLX 160.2M
- IPO Year
- BCBP N/A
- PLX 1998
- Fundamental
- Price
- BCBP $8.10
- PLX $1.55
- Analyst Decision
- BCBP Hold
- PLX Strong Buy
- Analyst Count
- BCBP 2
- PLX 1
- Target Price
- BCBP $11.75
- PLX $15.00
- AVG Volume (30 Days)
- BCBP 63.7K
- PLX 1.4M
- Earning Date
- BCBP 07-18-2025
- PLX 05-09-2025
- Dividend Yield
- BCBP 7.89%
- PLX N/A
- EPS Growth
- BCBP N/A
- PLX N/A
- EPS
- BCBP 0.15
- PLX 0.05
- Revenue
- BCBP $63,178,000.00
- PLX $59,764,000.00
- Revenue This Year
- BCBP $22.41
- PLX $65.02
- Revenue Next Year
- BCBP $10.90
- PLX $57.34
- P/E Ratio
- BCBP $54.10
- PLX $32.18
- Revenue Growth
- BCBP N/A
- PLX 0.18
- 52 Week Low
- BCBP $7.92
- PLX $0.82
- 52 Week High
- BCBP $14.04
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- BCBP 38.95
- PLX 30.03
- Support Level
- BCBP $7.92
- PLX $1.54
- Resistance Level
- BCBP $8.24
- PLX $1.79
- Average True Range (ATR)
- BCBP 0.17
- PLX 0.11
- MACD
- BCBP 0.02
- PLX -0.02
- Stochastic Oscillator
- BCBP 24.00
- PLX 27.27
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.